<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0123-3122</journal-id>
<journal-title><![CDATA[Persona y Bioética]]></journal-title>
<abbrev-journal-title><![CDATA[pers.bioét.]]></abbrev-journal-title>
<issn>0123-3122</issn>
<publisher>
<publisher-name><![CDATA[Universidad de la Sabana]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0123-31222017000100023</article-id>
<article-id pub-id-type="doi">10.5294/pebi.2017.21.1.3</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Naprotecnología: ciencia y persona en la infección por el virus del papiloma humano (vph) en mujeres y preadolescentes]]></article-title>
<article-title xml:lang="en"><![CDATA[NaProTechnology: Science and the Person in Human Papillomavirus (HPV) Infection among Women and Preadolescents]]></article-title>
<article-title xml:lang="pt"><![CDATA[Naprotecnologia: ciência e pessoa na infecção por Papilomavírus Humano (HPV) em mulheres e pré-adolescentes]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Murcia-Lora]]></surname>
<given-names><![CDATA[José María]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Esparza-Encina]]></surname>
<given-names><![CDATA[María Luisa]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Alcázar-Zambrano]]></surname>
<given-names><![CDATA[Juan Luis]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martínez-Calvo]]></surname>
<given-names><![CDATA[María Ángeles]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cabrera-Muro]]></surname>
<given-names><![CDATA[Rocío]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,NaProTechnology and Functional Reproductive Medicine, Clinical Consulting G&amp;E  ]]></institution>
<addr-line><![CDATA[Logroño ]]></addr-line>
<country>España</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Clinical Consulting G&amp;E  ]]></institution>
<addr-line><![CDATA[Logroño La Rioja]]></addr-line>
<country>España</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad de Navarra  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Spain</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Universidad de La Rioja  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Spain</country>
</aff>
<aff id="Af5">
<institution><![CDATA[,Instituto Valenciano de Fertilidad (IVAF) y del Instituto Pontificio Juan Pablo II  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>España</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>01</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>01</month>
<year>2017</year>
</pub-date>
<volume>21</volume>
<numero>1</numero>
<fpage>23</fpage>
<lpage>45</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0123-31222017000100023&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0123-31222017000100023&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0123-31222017000100023&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen En la actualidad hay suficiente evidencia científica que relaciona directamente la adquisición, exposición y prevalencia del virus del papiloma humano (VPH) con el cáncer del cuello de uterino. Por ello, el artículo aborda el VPH en la mujer teniendo en cuenta la naprotecnología, que permite conjugar evidencia científica y planteamientos éticos. Se busca que se tengan en cuenta tanto el aspecto biológico de la sexualidad como la capacidad de hacerse persona en su núcleo sexual. De ahí que se analicen programas dirigidos a la educación sexual, basados tanto en la prevención sanitaria como en la antropología de la sexualidad, y apoyados por las instituciones familiares, que han demostrado una mejor acogida ante los riesgos de las enfermedades de transmisión sexual, y entre ellas la infección por el VPH.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract There currently is sufficient scientific evidence directly linking acquisition, exposure and prevalence of the human papillomavirus (HPV) to cervical cancer. The article addresses HPV in women by taking NaProTechnology into account, which makes it possible to combine scientific evidence with ethical approaches. It looks at both the biological aspect of sexuality and the ability to become a person within one&#8217;s sexual nucleus. There is an analysis of sex education programs based on preventive health and on the anthropology of sexuality, and supported by family institutions, that have demonstrated better acceptance in dealing with the risk of sexually transmitted diseases, including HPV infection.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo Na atualidade, há suficiente evidência científica que relaciona diretamente aquisição, exposição e prevalência do Papilomavírus Humano (HPV) com o câncer do colo do útero. Por isso, este artigo aborda o HPV na mulher considerando a naprotecnologia, que permite conjugar evidência científica e proposições éticas. Procura-se que sejam levados em conta tanto o aspecto biológico da sexualidade quanto a capacidade de se fazer pessoa em seu núcleo sexual. A partir disso, são analisados programas dirigidos à educação sexual, baseados tanto na prevenção sanitária quanto na antropologia da sexualidade, e apoiados pelas instituições familiares, que têm demonstrado uma melhor acolhida diante dos riscos das infecções de transmissão sexual e, entre elas, a infecção pelo HPV.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[naprotecnología]]></kwd>
<kwd lng="es"><![CDATA[virus del papiloma humano (VPH)]]></kwd>
<kwd lng="es"><![CDATA[vacunación]]></kwd>
<kwd lng="es"><![CDATA[antropología]]></kwd>
<kwd lng="es"><![CDATA[sexualidad]]></kwd>
<kwd lng="es"><![CDATA[preadolescencia]]></kwd>
<kwd lng="en"><![CDATA[NaProTecnology]]></kwd>
<kwd lng="en"><![CDATA[human papilloma virus (HPV)]]></kwd>
<kwd lng="en"><![CDATA[vaccination]]></kwd>
<kwd lng="en"><![CDATA[anthropology]]></kwd>
<kwd lng="en"><![CDATA[sexuality]]></kwd>
<kwd lng="en"><![CDATA[preadolescence]]></kwd>
<kwd lng="pt"><![CDATA[antropologia]]></kwd>
<kwd lng="pt"><![CDATA[naprotecnologia]]></kwd>
<kwd lng="pt"><![CDATA[papilomavírus humano (HPV)]]></kwd>
<kwd lng="pt"><![CDATA[pré-adolescência]]></kwd>
<kwd lng="pt"><![CDATA[sexualidade]]></kwd>
<kwd lng="pt"><![CDATA[vacinação]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schiffman]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Castle]]></surname>
<given-names><![CDATA[PE]]></given-names>
</name>
<name>
<surname><![CDATA[Jeronimo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Rodriguez]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Wacholder]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Human papillomavirus and cervical cancer]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2007</year>
<volume>370</volume>
<numero>9590</numero>
<issue>9590</issue>
<page-range>890-907</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Markowitz]]></surname>
<given-names><![CDATA[LE]]></given-names>
</name>
<name>
<surname><![CDATA[Hariri]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Panicker]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Unger]]></surname>
<given-names><![CDATA[ER.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Seroprevalence of 9 human papillomavirus types in the United States, 2005-2006.]]></article-title>
<source><![CDATA[J Infect Dis.]]></source>
<year>2015</year>
</nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rositch]]></surname>
<given-names><![CDATA[AF]]></given-names>
</name>
<name>
<surname><![CDATA[Burke]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
<name>
<surname><![CDATA[Viscidi]]></surname>
<given-names><![CDATA[RP]]></given-names>
</name>
<name>
<surname><![CDATA[Silver]]></surname>
<given-names><![CDATA[MI]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Gravitt]]></surname>
<given-names><![CDATA[PE.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women.]]></article-title>
<source><![CDATA[Cancer Res.]]></source>
<year>2012</year>
<volume>72</volume>
<numero>23</numero>
<issue>23</issue>
<page-range>6183-90</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Strickler]]></surname>
<given-names><![CDATA[HD]]></given-names>
</name>
<name>
<surname><![CDATA[Burk]]></surname>
<given-names><![CDATA[RD]]></given-names>
</name>
<name>
<surname><![CDATA[Fazzari]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Anastos]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Minkoff]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Massad]]></surname>
<given-names><![CDATA[LS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.]]></article-title>
<source><![CDATA[J Natl Cancer Inst.]]></source>
<year>2005</year>
<numero>97</numero>
<issue>97</issue>
<page-range>577-86</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cómbita]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Respuesta sexológica hacia partículas semejantes a virus en los papilomavirus oncogénicos tipo 16, 18, 31, 33, 39, 58 y 59 en mujeres colombianas con cáncer invasivo.]]></article-title>
<source><![CDATA[Rev Asoc Colomb Alerg Asma Inmuno]]></source>
<year>2002</year>
<volume>11</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Sanjose]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Quint]]></surname>
<given-names><![CDATA[WG]]></given-names>
</name>
<name>
<surname><![CDATA[Alemany]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Geraets]]></surname>
<given-names><![CDATA[DT]]></given-names>
</name>
<name>
<surname><![CDATA[Klaustermeier]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Lloveras]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.]]></article-title>
<source><![CDATA[Lancet Oncol.]]></source>
<year>2010</year>
<numero>11</numero>
<issue>11</issue>
<page-range>1048-56</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Walboomers]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Jacobs]]></surname>
<given-names><![CDATA[MV]]></given-names>
</name>
<name>
<surname><![CDATA[Manos]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Bosch]]></surname>
<given-names><![CDATA[FX]]></given-names>
</name>
<name>
<surname><![CDATA[Kummer]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Shah]]></surname>
<given-names><![CDATA[KV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.]]></article-title>
<source><![CDATA[J Pathol.]]></source>
<year>1999</year>
<volume>189</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>12-9</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guan]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer.]]></article-title>
<source><![CDATA[Int J Cancer.]]></source>
<year>2012</year>
<numero>131</numero>
<issue>131</issue>
<page-range>2349-59</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="">
<collab>Center for Disease Control and Prevention</collab>
<source><![CDATA[Incidence, prevalence, and cost of sexually transmitted infections in the United States]]></source>
<year>2013</year>
</nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bosch]]></surname>
<given-names><![CDATA[FX]]></given-names>
</name>
<name>
<surname><![CDATA[de Sanjosé]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Castellsaqué]]></surname>
<given-names><![CDATA[X.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Human papilloma virus: Oncogenic risk and new opportunities for prevention.]]></article-title>
<source><![CDATA[An Sist Sanit Navar.]]></source>
<year>2001</year>
<volume>24</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>7-13</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Palmer]]></surname>
<given-names><![CDATA[AK]]></given-names>
</name>
<name>
<surname><![CDATA[Harris]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Jacobson]]></surname>
<given-names><![CDATA[RM.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Human papillomavirus vaccination: a case study in translational science]]></article-title>
<source><![CDATA[Clin Transl Sci.]]></source>
<year>2014</year>
<volume>7</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>420-4</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dunne]]></surname>
<given-names><![CDATA[EF]]></given-names>
</name>
<name>
<surname><![CDATA[Unger]]></surname>
<given-names><![CDATA[ER]]></given-names>
</name>
<name>
<surname><![CDATA[Sternberg]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[McQuillan]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Swan]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
<name>
<surname><![CDATA[Patel]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence of HPV infection among females in the United States]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2007</year>
<volume>297</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>813-9</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chesson]]></surname>
<given-names><![CDATA[HW]]></given-names>
</name>
<name>
<surname><![CDATA[Dunne]]></surname>
<given-names><![CDATA[EF]]></given-names>
</name>
<name>
<surname><![CDATA[Hariri]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Markowitz]]></surname>
<given-names><![CDATA[LE.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The estimated lifetime probability of acquiring human papillomavirus in the United States.]]></article-title>
<source><![CDATA[Sex Transm Dis.]]></source>
<year>2014</year>
<numero>41</numero>
<issue>41</issue>
<page-range>660-4</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dunne]]></surname>
<given-names><![CDATA[EF]]></given-names>
</name>
<name>
<surname><![CDATA[Unger]]></surname>
<given-names><![CDATA[ER]]></given-names>
</name>
<name>
<surname><![CDATA[Sternberg]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[McQuillan]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Swan]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
<name>
<surname><![CDATA[Patel]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence of HPV infection among females in the United States.]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2007</year>
<volume>297</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>813-9</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Markowitz]]></surname>
<given-names><![CDATA[LE]]></given-names>
</name>
<name>
<surname><![CDATA[Sternberg]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Dunne]]></surname>
<given-names><![CDATA[EF]]></given-names>
</name>
<name>
<surname><![CDATA[McQuillan]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Unger]]></surname>
<given-names><![CDATA[ER.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004]]></article-title>
<source><![CDATA[J Infect Dis.]]></source>
<year>2009</year>
<numero>200</numero>
<issue>200</issue>
<page-range>1059-67</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stokley]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Jeyarajah]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Yankey]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014-United States]]></article-title>
<source><![CDATA[MMWR Morb Mortal Wkly Rep]]></source>
<year>2014</year>
<numero>63</numero>
<issue>63</issue>
<page-range>620-4</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Markowitz]]></surname>
<given-names><![CDATA[LE]]></given-names>
</name>
<name>
<surname><![CDATA[Hariri]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Panicker]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Unger]]></surname>
<given-names><![CDATA[ER.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Seroprevalence of 9 human papillomavirus types in the United States, 2005-2006]]></article-title>
<source><![CDATA[J Infect Dis.]]></source>
<year>2015</year>
</nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fanfair]]></surname>
<given-names><![CDATA[SL]]></given-names>
</name>
<name>
<surname><![CDATA[Zaidi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Taylor]]></surname>
<given-names><![CDATA[LD]]></given-names>
</name>
<name>
<surname><![CDATA[Xu]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Gottlieb]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Markowitz]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trends in seroprevalence of herpes simplex virus type 2 among non-Hispanic blacks and non-Hispanic whites aged 14 to 49 years-United States, 1988-2010.]]></article-title>
<source><![CDATA[Sex Transm Infect.]]></source>
<year>2013</year>
<numero>40</numero>
<issue>40</issue>
<page-range>860-4</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bate]]></surname>
<given-names><![CDATA[SL]]></given-names>
</name>
<name>
<surname><![CDATA[Dollard]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Cannon]]></surname>
<given-names><![CDATA[MJ.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cytomegalovirus seroprevalence in the United States: the National Health and Nutrition Examination Surveys, 1988-2004.]]></article-title>
<source><![CDATA[Clin Infect Dis.]]></source>
<year>2010</year>
<numero>50</numero>
<issue>50</issue>
<page-range>1439-47</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Winer]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Hughes]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Feng]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women.]]></article-title>
<source><![CDATA[Cancer Epidemiol Biomarkers Prev.]]></source>
<year>2011</year>
<numero>20</numero>
<issue>20</issue>
<page-range>699-707</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Giuliano]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[J-H]]></given-names>
</name>
<name>
<surname><![CDATA[Fulp]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidence and clearance of genital human papillomavirus infection in men (HIM): A cohort study.]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2011</year>
<numero>377</numero>
<issue>377</issue>
<page-range>932-40</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Widdice]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Ma]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Jonte]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Concordance and transmission of human papillomavirus within heterosexual couples observed over short intervals.]]></article-title>
<source><![CDATA[J Infect Dis.]]></source>
<year>2013</year>
<numero>207</numero>
<issue>207</issue>
<page-range>1286-94</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mbulawa]]></surname>
<given-names><![CDATA[ZZ]]></given-names>
</name>
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[LF]]></given-names>
</name>
<name>
<surname><![CDATA[Marais]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Coetzee]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Williamson]]></surname>
<given-names><![CDATA[AL.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The impact of human immunodeficiency virus on human papillomavirus transmission in heterosexually active couples]]></article-title>
<source><![CDATA[J Infect]]></source>
<year>2013</year>
<numero>67</numero>
<issue>67</issue>
<page-range>51-8</page-range></nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hernandez]]></surname>
<given-names><![CDATA[BY]]></given-names>
</name>
<name>
<surname><![CDATA[Wilkens]]></surname>
<given-names><![CDATA[LR]]></given-names>
</name>
<name>
<surname><![CDATA[Zhu]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Transmission of human papillomavirus in heterosexual couples]]></article-title>
<source><![CDATA[Emerg Infect Dis.]]></source>
<year>2008</year>
<numero>14</numero>
<issue>14</issue>
<page-range>888-94</page-range></nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Burchell]]></surname>
<given-names><![CDATA[AN]]></given-names>
</name>
<name>
<surname><![CDATA[Coutlee]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Tellier]]></surname>
<given-names><![CDATA[PP]]></given-names>
</name>
<name>
<surname><![CDATA[Hanley]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Franco]]></surname>
<given-names><![CDATA[EL.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Genital transmission of human papillomavirus in recently formed heterosexual couples.]]></article-title>
<source><![CDATA[J Infect Dis.]]></source>
<year>2011</year>
<numero>204</numero>
<issue>204</issue>
<page-range>1723-9</page-range></nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Anic]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
<name>
<surname><![CDATA[Stockwell]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidence and human papillomavirus (HPV) type distribution of genital warts in a multinational cohort of men: the HPV in men study.]]></article-title>
<source><![CDATA[J Infect Dis.]]></source>
<year>2011</year>
<numero>204</numero>
<issue>204</issue>
<page-range>1886-92</page-range></nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arima]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Winer]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Feng]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development of genital warts after incident detection of human papillomavirus infection in young men.]]></article-title>
<source><![CDATA[J Infect Dis.]]></source>
<year>2010</year>
<numero>202</numero>
<issue>202</issue>
<page-range>1181-4</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Garland]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Steben]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sings]]></surname>
<given-names><![CDATA[HL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine.]]></article-title>
<source><![CDATA[J Infect Dis.]]></source>
<year>2009</year>
<numero>199</numero>
<issue>199</issue>
<page-range>805-14</page-range></nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Winer]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Kiviat]]></surname>
<given-names><![CDATA[NB]]></given-names>
</name>
<name>
<surname><![CDATA[Hughes]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development and duration of human papillomavirus lesions, after initial infection.]]></article-title>
<source><![CDATA[J Infect Dis.]]></source>
<year>2005</year>
<numero>191</numero>
<issue>191</issue>
<page-range>731-8</page-range></nlm-citation>
</ref>
<ref id="B30">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Massad]]></surname>
<given-names><![CDATA[LS]]></given-names>
</name>
<name>
<surname><![CDATA[Xie]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Darragh]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Genital warts and vulvar intraepithelial neoplasia: natural history and effects of treatment and human immunodeficiency virus infection.]]></article-title>
<source><![CDATA[Obstet Gynecol.]]></source>
<year>2011</year>
<numero>118</numero>
<issue>118</issue>
<page-range>831-9</page-range></nlm-citation>
</ref>
<ref id="B31">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Commite Opinion no. 641: Human Papillomavirus Vaccination]]></article-title>
<source><![CDATA[Obstet Gynecol.]]></source>
<year>2015</year>
<volume>126</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>e38-43</page-range></nlm-citation>
</ref>
<ref id="B32">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chesson]]></surname>
<given-names><![CDATA[HW]]></given-names>
</name>
<name>
<surname><![CDATA[Dunne]]></surname>
<given-names><![CDATA[EF]]></given-names>
</name>
<name>
<surname><![CDATA[Hariri]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Markowitz]]></surname>
<given-names><![CDATA[LE.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The estimated lifetime probability of acquiring human papillomavirus in the United States.]]></article-title>
<source><![CDATA[Sex Transm Dis.]]></source>
<year>2014</year>
<numero>41</numero>
<issue>41</issue>
<page-range>660-4</page-range></nlm-citation>
</ref>
<ref id="B33">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Satterwhite]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Torrone]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Meites]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008.]]></article-title>
<source><![CDATA[Sex Transm Dis.]]></source>
<year>2013</year>
<numero>40</numero>
<issue>40</issue>
<page-range>187-93</page-range></nlm-citation>
</ref>
<ref id="B34">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jemal]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Simard]]></surname>
<given-names><![CDATA[EP]]></given-names>
</name>
<name>
<surname><![CDATA[Dorell]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Annual report to the nation on the status of cancer, 1975-2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels.]]></article-title>
<source><![CDATA[J Natl Cancer Inst.]]></source>
<year>2013</year>
<numero>105</numero>
<issue>105</issue>
<page-range>175-201</page-range></nlm-citation>
</ref>
<ref id="B35">
<nlm-citation citation-type="book">
<collab>Sociedad Española de Ginecología y Obstetricia (SEGO)</collab>
<source><![CDATA[Guías de práctica clínica en cáncer ginecológico y mamario]]></source>
<year>2014</year>
<volume>9</volume>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Publicaciones SEGO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B36">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wright]]></surname>
<given-names><![CDATA[TC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of the Papnet Cytologic Scfeening System for quality control of cervical smears.]]></article-title>
<source><![CDATA[Am J Clin Pathol.]]></source>
<year>1994</year>
<numero>101</numero>
<issue>101</issue>
<page-range>220-9</page-range></nlm-citation>
</ref>
<ref id="B37">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bosch]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Lorincz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Muñoz]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Meijer]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Shah]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The causal relation between human papillomavirus and cervical cancer.]]></article-title>
<source><![CDATA[J Clin Pathol.]]></source>
<year>2002</year>
<volume>55</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>244-65</page-range></nlm-citation>
</ref>
<ref id="B38">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kreimer]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Struyf]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Del Rosario-Raymundo]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Hildesheim]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Skinner]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
<name>
<surname><![CDATA[Wacholder]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials.]]></article-title>
<source><![CDATA[Lancet Oncol.]]></source>
<year>2015</year>
<volume>16</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>775-86</page-range></nlm-citation>
</ref>
<ref id="B39">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nowakowski]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Kotarski]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk factors of cervical cancer and possibilities of primary prevention.]]></article-title>
<source><![CDATA[Przegl Epidemiol.]]></source>
<year>2011</year>
<volume>65</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>81-8</page-range></nlm-citation>
</ref>
<ref id="B40">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schiffman]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Wentzensen]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[From human papillomavirus to cervical cancer.]]></article-title>
<source><![CDATA[Obstet Gynecol.]]></source>
<year>2010</year>
<volume>116</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>177-85</page-range></nlm-citation>
</ref>
<ref id="B41">
<nlm-citation citation-type="">
<collab>Ministerio de Sanidad Servicios Sociales e Igualdad</collab>
<source><![CDATA[Estudio INJUVE EJ155]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B42">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Remschmidt]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Fesenfeld]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Kaufmann]]></surname>
<given-names><![CDATA[AM.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sexual behavior and factors associated with young age at first intercourse and HPV vaccine uptake among young women in Germany: implications for HPV vaccination policies.]]></article-title>
<source><![CDATA[BMC Public Health]]></source>
<year>2014</year>
<numero>14</numero>
<issue>14</issue>
<page-range>1248</page-range></nlm-citation>
</ref>
<ref id="B43">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Myers]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Lytle]]></surname>
<given-names><![CDATA[CD]]></given-names>
</name>
<name>
<surname><![CDATA[Routson]]></surname>
<given-names><![CDATA[LB.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A mathematical model for simulating virus transport through synthetic barriers.]]></article-title>
<source><![CDATA[Bull Math Biol.]]></source>
<year>1999</year>
<volume>61</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>113-40</page-range></nlm-citation>
</ref>
<ref id="B44">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Myers]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Das]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Virus transmission through compromised synthetic barriers. I- effect of unsteady driving pressures.]]></article-title>
<source><![CDATA[J Biomech Eng.]]></source>
<year>2001</year>
<volume>123</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>506-12</page-range></nlm-citation>
</ref>
<ref id="B45">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Das]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Myers]]></surname>
<given-names><![CDATA[MR.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Virus transmission through compromised synthetic barriers: II-f poor geometry.]]></article-title>
<source><![CDATA[J Biomech Eng.]]></source>
<year>2001</year>
<volume>123</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>513-8</page-range></nlm-citation>
</ref>
<ref id="B46">
<nlm-citation citation-type="">
<collab>UNAIDS</collab>
<source><![CDATA[Sexual behavioural change for HIV: Where have theories taken us? UNAIDS Best Practice Collection]]></source>
<year>1999</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B47">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cates]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Hinman]]></surname>
<given-names><![CDATA[AR.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[AIDS and absolutism: The demand for perfection in prevention.]]></article-title>
<source><![CDATA[N Eng J Med.]]></source>
<year>1992</year>
<volume>327</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>492-4</page-range></nlm-citation>
</ref>
<ref id="B48">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[April]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Koster]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Fantacci]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Qual è il grado effetivo di protezione dall&#8217;HIV del preservativo?]]></article-title>
<source><![CDATA[Medicina e Morale.]]></source>
<year>1994</year>
<volume>44</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>903-5</page-range></nlm-citation>
</ref>
<ref id="B49">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chesson]]></surname>
<given-names><![CDATA[HW]]></given-names>
</name>
<name>
<surname><![CDATA[Dunne]]></surname>
<given-names><![CDATA[EF]]></given-names>
</name>
<name>
<surname><![CDATA[Hariri]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Markowitz]]></surname>
<given-names><![CDATA[LE.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The estimated lifetime probability of acquiring human papillomavirus in the United States.]]></article-title>
<source><![CDATA[Sex Transm Dis.]]></source>
<year>2014</year>
<numero>41</numero>
<issue>41</issue>
<page-range>660-4</page-range></nlm-citation>
</ref>
<ref id="B50">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cone]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mocus]]></article-title>
<source><![CDATA[Mucosal immunology]]></source>
<year>2005</year>
<page-range>49-72</page-range><publisher-loc><![CDATA[Burlington ]]></publisher-loc>
<publisher-name><![CDATA[Elsevier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B51">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gipson]]></surname>
<given-names><![CDATA[IK.]]></given-names>
</name>
</person-group>
<source><![CDATA[Human endocervical mucins]]></source>
<year>2005</year>
<page-range>219-44</page-range></nlm-citation>
</ref>
<ref id="B52">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Knowles]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Boucher]]></surname>
<given-names><![CDATA[RC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mucus clearance as a primary innate defense mechanism for mammalian airways.]]></article-title>
<source><![CDATA[J Clin Invest.]]></source>
<year>2002</year>
<numero>109</numero>
<issue>109</issue>
<page-range>571-7</page-range></nlm-citation>
</ref>
<ref id="B53">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chilvers]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[O&#8217;Callaghan]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Local mucociliary defence mechanisms.]]></article-title>
<source><![CDATA[Paediatr Respir Rev.]]></source>
<year>2000</year>
<numero>1</numero>
<issue>1</issue>
<page-range>27-34</page-range></nlm-citation>
</ref>
<ref id="B54">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Olmsted]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diffusion of macromolecules and virus-like particles in human cervical mucus.]]></article-title>
<source><![CDATA[Biophys J.]]></source>
<year>2001</year>
<numero>81</numero>
<issue>81</issue>
<page-range>1930-7</page-range></nlm-citation>
</ref>
<ref id="B55">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carlstedt]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Sheehan]]></surname>
<given-names><![CDATA[JK.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Structure and macromolecular properties of cervical mucus glycoproteins.]]></article-title>
<source><![CDATA[Symp Soc Exp Biol.]]></source>
<year>1989</year>
<numero>43</numero>
<issue>43</issue>
<page-range>289-316</page-range></nlm-citation>
</ref>
<ref id="B56">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lai]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus.]]></article-title>
<source><![CDATA[Proc Natl Acad Sci USA.]]></source>
<year>2007</year>
<numero>104</numero>
<issue>104</issue>
<page-range>1482-7</page-range></nlm-citation>
</ref>
<ref id="B57">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lai]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[YY]]></given-names>
</name>
<name>
<surname><![CDATA[Hanes]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues.]]></article-title>
<source><![CDATA[Adv Drug Deliv Rev.]]></source>
<year>2009</year>
<numero>61</numero>
<issue>61</issue>
<page-range>158-71</page-range></nlm-citation>
</ref>
<ref id="B58">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lai]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[YY]]></given-names>
</name>
<name>
<surname><![CDATA[Wirtz]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Hanes]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Micro- and macrorheology of mucus]]></article-title>
<source><![CDATA[Adv Drug Deliv Rev.]]></source>
<year>2009</year>
<numero>61</numero>
<issue>61</issue>
<page-range>86-100</page-range></nlm-citation>
</ref>
<ref id="B59">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lai]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[YY]]></given-names>
</name>
<name>
<surname><![CDATA[Hida]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Cone]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Hanes]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Langer]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses.]]></article-title>
<source><![CDATA[Proc Natl Acad Sci USA.]]></source>
<year>2010</year>
<volume>107</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>598-603</page-range></nlm-citation>
</ref>
<ref id="B60">
<nlm-citation citation-type="book">
<collab>Department of Health and Human Services, Public Health Service</collab>
<source><![CDATA[Sexually-transmitted diseased surveillance, 1994.]]></source>
<year>1995</year>
<publisher-loc><![CDATA[Atlanta ]]></publisher-loc>
<publisher-name><![CDATA[Center for Disease Control]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B61">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moreno]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Bosch]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Munoz]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of oral contraceptives on risk cervical cancer in women with human papilloma virus infection: The LARC Multicentric Case-Control Study.]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2002</year>
<numero>359</numero>
<issue>359</issue>
<page-range>1085-92</page-range></nlm-citation>
</ref>
<ref id="B62">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hilgers]]></surname>
<given-names><![CDATA[TW.]]></given-names>
</name>
</person-group>
<source><![CDATA[The medical &amp; surgical practice of naprotechnology.]]></source>
<year>2004</year>
<edition>1st</edition>
<publisher-loc><![CDATA[Omaha, USA ]]></publisher-loc>
<publisher-name><![CDATA[Pope Paul VI Institute Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B63">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bernard]]></surname>
<given-names><![CDATA[HU]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments.]]></article-title>
<source><![CDATA[Virology]]></source>
<year>2010</year>
<numero>401</numero>
<issue>401</issue>
<page-range>70-9</page-range></nlm-citation>
</ref>
<ref id="B64">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Markowitz]]></surname>
<given-names><![CDATA[LE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).]]></article-title>
<source><![CDATA[Morbidity and Mortality Weekly Report Recommendations and Reports]]></source>
<year>2007</year>
<numero>56</numero>
<issue>56</issue>
<page-range>1-24</page-range></nlm-citation>
</ref>
<ref id="B65">
<nlm-citation citation-type="journal">
<collab>Center for Disease Control and Prevention</collab>
<article-title xml:lang=""><![CDATA[FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Prophylactic HPV vaccination: past, present, and future 463 Advisory Committee on Immunization Practices (ACIP).]]></article-title>
<source><![CDATA[Morbidity and Mortality Weekly Report.]]></source>
<year>2010</year>
<numero>59</numero>
<issue>59</issue>
<page-range>626-9</page-range></nlm-citation>
</ref>
<ref id="B66">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Markowitz]]></surname>
<given-names><![CDATA[LE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vacuna tetravalente contra el virus del papiloma humano: Recomendaciones del Comité Asesor sobre Prácticas de Inmunización (ACIP): la morbilidad y mortalidad de informe semanal.]]></article-title>
<source><![CDATA[Recomendaciones e Informes]]></source>
<year>2007</year>
<numero>56</numero>
<issue>56</issue>
<page-range>1-24</page-range></nlm-citation>
</ref>
<ref id="B67">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saslow]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Castle]]></surname>
<given-names><![CDATA[PE]]></given-names>
</name>
<name>
<surname><![CDATA[Cox]]></surname>
<given-names><![CDATA[JT]]></given-names>
</name>
<name>
<surname><![CDATA[Davey]]></surname>
<given-names><![CDATA[DD]]></given-names>
</name>
<name>
<surname><![CDATA[Einstein]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors.]]></article-title>
<source><![CDATA[CA Cancer J Clin.]]></source>
<year>2007</year>
<numero>57</numero>
<issue>57</issue>
<page-range>7-28</page-range></nlm-citation>
</ref>
<ref id="B68">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Committee Opinion no. 641: Human Papillomavirus Vaccination]]></article-title>
<source><![CDATA[Obstet Gynecol.]]></source>
<year>2015</year>
<volume>126</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>e38-43</page-range></nlm-citation>
</ref>
<ref id="B69">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Delere]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Wichmann]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Klug]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[van der Sande]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Terhardt]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Zepp]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The efficacy and duration of vaccine protection against human papillomavirus.]]></article-title>
<source><![CDATA[Dtsch Arztehl Int.]]></source>
<year>2014</year>
<numero>111</numero>
<issue>111</issue>
<page-range>584-91</page-range></nlm-citation>
</ref>
<ref id="B70">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Konno]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Yoshikawa]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Okutani]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Quint]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Suryakiran]]></surname>
<given-names><![CDATA[PV]]></given-names>
</name>
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efficacy of the human papillomavirus (HPV)-16/18 ASO4-adjuvanted vaccine against cervical intraepithelial neoplasia and cervical infection in young Japanese women]]></article-title>
<source><![CDATA[Hum Vaccine Immunother.]]></source>
<year>2014</year>
<volume>10</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1781-94</page-range></nlm-citation>
</ref>
<ref id="B71">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cuzick]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Gardasil 9 joins the fight against cervix cancer.]]></article-title>
<source><![CDATA[Expert Rev Vaccines]]></source>
<year>2015</year>
<volume>14</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1047-9</page-range></nlm-citation>
</ref>
<ref id="B72">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Trimble]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Morrow]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
<name>
<surname><![CDATA[Kraynyak]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
<name>
<surname><![CDATA[Shen]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Dallas]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Tan]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomized, double-blind, placebo-controlled phase 2b trial]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2015</year>
<volume>386</volume>
<numero>10008</numero>
<issue>10008</issue>
<page-range>2078-88</page-range></nlm-citation>
</ref>
<ref id="B73">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baldur-Felskov]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Dehlendorff]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Junge]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Munk]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Kjaer]]></surname>
<given-names><![CDATA[SK.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidence of cervical lesions in Danish women before and after implementation of a national HPV vaccination program.]]></article-title>
<source><![CDATA[Cancer Causes Control.]]></source>
<year>2014</year>
<numero>25</numero>
<issue>25</issue>
<page-range>915-22</page-range></nlm-citation>
</ref>
<ref id="B74">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Niccolai]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Julian]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Meek]]></surname>
<given-names><![CDATA[JI]]></given-names>
</name>
<name>
<surname><![CDATA[McBride]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Hadler]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Sosa]]></surname>
<given-names><![CDATA[LE.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Declining rates of high-grade cervical lesions in young women in Connecticut, 2008-2011.]]></article-title>
<source><![CDATA[Cancer Epidemiol Biomarkers Prev.]]></source>
<year>2013</year>
<volume>22</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1446-50</page-range></nlm-citation>
</ref>
<ref id="B75">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Puig-Tintoré]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
</person-group>
<source><![CDATA[La infección por papilomavirus. Documentos de Consenso.]]></source>
<year>2002</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[SEGO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B76">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Delere]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Wichmann]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Klug]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[van der Sande]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Terhardt]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Zepp]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The efficacy and duration of vaccine protection against human papillomavirus.]]></article-title>
<source><![CDATA[Dtsch Arztehl Int.]]></source>
<year>2014</year>
<numero>111</numero>
<issue>111</issue>
<page-range>584-91</page-range></nlm-citation>
</ref>
<ref id="B77">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Petrosky]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Bocchini]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Hariri]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Chesson]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Curtis]]></surname>
<given-names><![CDATA[CR]]></given-names>
</name>
<name>
<surname><![CDATA[Sariya]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.]]></article-title>
<source><![CDATA[MMWR]]></source>
<year>2015</year>
<volume>64</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>300-4</page-range></nlm-citation>
</ref>
<ref id="B78">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Torné]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Alonso]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Puig-Tintoré]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Pahisa]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical role of cervical cancer vaccination: when and whom to vaccinate?]]></article-title>
<source><![CDATA[Gynecol Oncol.]]></source>
<year>2008</year>
<month>;S</month>
<day>ep</day>
<volume>110</volume>
<numero>3^s2</numero>
<issue>3^s2</issue>
<supplement>2</supplement>
<page-range>S15-6</page-range></nlm-citation>
</ref>
<ref id="B79">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Murcia]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Esparza]]></surname>
<given-names><![CDATA[ML.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A propósito de un caso: ovulación y Diane 35, perspectivas actuales en detección y control de la fertilidad.]]></article-title>
<source><![CDATA[Revista Médica Universidad de Navarra]]></source>
<year>2006</year>
<volume>50</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B80">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alonso]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[de Irala]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Strategies in HIV prevention: The A-B-C approach.]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2004</year>
<volume>364</volume>
<numero>9439</numero>
<issue>9439</issue>
<page-range>1033</page-range></nlm-citation>
</ref>
<ref id="B81">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lerner]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[&#8220;Can abstinence work?: An analysis of the best friends program.]]></article-title>
<source><![CDATA[Adolescent Fam Health J.]]></source>
<year>2005</year>
<volume>3</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B82">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Contreras]]></surname>
<given-names><![CDATA[JM.]]></given-names>
</name>
</person-group>
<source><![CDATA[Entre tú y yo: una relación inteligente.]]></source>
<year>1988</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Doce Calles]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B83">
<nlm-citation citation-type="">
<source><![CDATA[American College of Pediatricians]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B84">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Aysa]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Sexo: un motivo para amar.]]></source>
<year>2004</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Palabra]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B85">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gotzon]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Saber amar con el cuerpo.]]></source>
<year>2005</year>
<edition>7ª</edition>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Palabra]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B86">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bruni]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Barrionuevo-Rosas]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Albero]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Aldea]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Serrano]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Valencia]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Human papillomavirus and related diseases report 2015]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[ICO Information Centre on HPV and Cancer (HPV Information Centre)]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B87">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Suba]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Raab]]></surname>
<given-names><![CDATA[SS.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[HPV vaccination: waiting for evidence of effectiveness]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2010</year>
<numero>375</numero>
<issue>375</issue>
<page-range>639-40</page-range></nlm-citation>
</ref>
<ref id="B88">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baldur-Felskov]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Early impact of human papillomavirus vaccination on cervical neoplasia - nationwide follow-up of young Danish women.]]></article-title>
<source><![CDATA[J Natl Cancer Inst.]]></source>
<year>2014</year>
<numero>106</numero>
<issue>106</issue>
</nlm-citation>
</ref>
<ref id="B89">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gertig]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study.]]></article-title>
<source><![CDATA[BMC Med.]]></source>
<year>2013</year>
<numero>11</numero>
<issue>11</issue>
<page-range>227</page-range></nlm-citation>
</ref>
<ref id="B90">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hariri]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States-2008-2012]]></article-title>
<source><![CDATA[Vaccine]]></source>
<year>2015</year>
<numero>33</numero>
<issue>33</issue>
<page-range>1608-11</page-range></nlm-citation>
</ref>
<ref id="B91">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vink]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical progression of high-grade cervical intraepithelial neoplasia: estimating the time to preclinical cervical cancer from doubly censored national registry data.]]></article-title>
<source><![CDATA[Am J Epidemiol.]]></source>
<year>2013</year>
<numero>178</numero>
<issue>178</issue>
<page-range>1161-9</page-range></nlm-citation>
</ref>
<ref id="B92">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McCredie]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study]]></article-title>
<source><![CDATA[Lancet Oncol]]></source>
<year>2008</year>
<numero>9</numero>
<issue>9</issue>
<page-range>425-34</page-range></nlm-citation>
</ref>
<ref id="B93">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Cervical Cancer Inquiry]]></article-title>
<source><![CDATA[New Zealand Nursing Forum]]></source>
<year>1988</year>
<numero>16</numero>
<issue>16</issue>
<page-range>5-6</page-range></nlm-citation>
</ref>
<ref id="B94">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schiffman]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[AC.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Heterogeneity in CIN3 diagnosis]]></article-title>
<source><![CDATA[Lancet Oncol]]></source>
<year>2008</year>
<numero>9</numero>
<issue>9</issue>
<page-range>404-6</page-range></nlm-citation>
</ref>
<ref id="B95">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vink]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La progresión clínica de alto grado neoplasia intraepitelial cervical: la estimación del tiempo para el cáncer cervical preclínica a partir de datos del registro nacional doblemente censurados.]]></article-title>
<source><![CDATA[Am J Epidemiol.]]></source>
<year>2013</year>
<numero>178</numero>
<issue>178</issue>
<page-range>1161-9</page-range></nlm-citation>
</ref>
<ref id="B96">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Darragh]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology]]></article-title>
<source><![CDATA[J Low Genit Tract Dis.]]></source>
<year>2012</year>
<numero>16</numero>
<issue>16</issue>
<page-range>205-42</page-range></nlm-citation>
</ref>
<ref id="B97">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jemal]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels.]]></article-title>
<source><![CDATA[J Natl Cancer Inst.]]></source>
<year>2013</year>
<numero>105</numero>
<issue>105</issue>
<page-range>175-201</page-range></nlm-citation>
</ref>
<ref id="B98">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Neuzil]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Immunogenicity and reactogenicity of alternative schedules of HPV vaccine in Vietnam: a cluster randomized noninferiority trial.]]></article-title>
<source><![CDATA[J Am Med Ass.]]></source>
<year>2011</year>
<numero>305</numero>
<issue>305</issue>
<page-range>1424-31</page-range></nlm-citation>
</ref>
<ref id="B99">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez-Rieiro]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Aragonés]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Pollan]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[López-Abente]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez-Gómez]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Temporal trends of cervical cancer mortality rates among regions in Spain: 1975-2004.]]></article-title>
<source><![CDATA[Med Clin (Barc).]]></source>
<year>2009</year>
<month>;J</month>
<day>un</day>
<volume>133</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>41-6</page-range></nlm-citation>
</ref>
<ref id="B100">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez González]]></surname>
<given-names><![CDATA[MA.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sobre la vacuna del papiloma]]></article-title>
<source><![CDATA[Diario de Navarra]]></source>
<year>2009</year>
</nlm-citation>
</ref>
<ref id="B101">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jena]]></surname>
<given-names><![CDATA[AB]]></given-names>
</name>
<name>
<surname><![CDATA[Goldman]]></surname>
<given-names><![CDATA[DP]]></given-names>
</name>
<name>
<surname><![CDATA[Sealbury]]></surname>
<given-names><![CDATA[SA.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidence of sexually transmitted infections after human papillomavirus vaccination among adolescent females.]]></article-title>
<source><![CDATA[JAMA Intern Med.]]></source>
<year>2015</year>
<volume>175</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>617-23</page-range></nlm-citation>
</ref>
<ref id="B102">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bednarczyk]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Davis]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Ault]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Orenstein]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Omer]]></surname>
<given-names><![CDATA[SB.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds.]]></article-title>
<source><![CDATA[Pediatrics]]></source>
<year>2012</year>
<volume>130</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>798-805</page-range></nlm-citation>
</ref>
<ref id="B103">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mollers]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[King]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Knol]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Scherpenisse]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Meijer]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[van der Klis]]></surname>
<given-names><![CDATA[FR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effectiveness of human papillomavirus vaccine against incident and persistent infections among young girls: results from a longitudinal Dutch cohort study.]]></article-title>
<source><![CDATA[Vaccine]]></source>
<year>2015</year>
<numero>33</numero>
<issue>33</issue>
<page-range>2678-83</page-range></nlm-citation>
</ref>
<ref id="B104">
<nlm-citation citation-type="">
<collab>WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre)</collab>
<source><![CDATA[Human papillomavirus and related cancers in world. Summary Report]]></source>
<year>2010</year>
</nlm-citation>
</ref>
<ref id="B105">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gertig]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study]]></article-title>
<source><![CDATA[BMC Med.]]></source>
<year>2013</year>
<numero>11</numero>
<issue>11</issue>
<page-range>227</page-range></nlm-citation>
</ref>
<ref id="B106">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kreimer]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Rodriguez]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Hildesheim]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Herrero]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Porras]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine.]]></article-title>
<source><![CDATA[J Natl Cancer Inst.]]></source>
<year>2011</year>
<numero>103</numero>
<issue>103</issue>
<page-range>1444-51</page-range></nlm-citation>
</ref>
<ref id="B107">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Safaeian]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses: results from the Costa Rica Vaccine Trial]]></article-title>
<source><![CDATA[Hum Vaccin Immunother]]></source>
<year>2013</year>
<volume>9</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1399-406</page-range></nlm-citation>
</ref>
<ref id="B108">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Noronha]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Markowitz]]></surname>
<given-names><![CDATA[LE]]></given-names>
</name>
<name>
<surname><![CDATA[Dunne]]></surname>
<given-names><![CDATA[EF.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Systematic review of human papillomavirus vaccine coadministration]]></article-title>
<source><![CDATA[Vaccine]]></source>
<year>2014</year>
<numero>32</numero>
<issue>32</issue>
</nlm-citation>
</ref>
<ref id="B109">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ferris]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Long-term study of a quadrivalent human papillomavirus vaccine]]></article-title>
<source><![CDATA[Pediatrics]]></source>
<year>2014</year>
<numero>134</numero>
<issue>134</issue>
<page-range>e657-65</page-range></nlm-citation>
</ref>
<ref id="B110">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Naud]]></surname>
<given-names><![CDATA[PS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine]]></article-title>
<source><![CDATA[Hum Vaccin Immunother]]></source>
<year>2014</year>
<numero>10</numero>
<issue>10</issue>
<page-range>2147-62</page-range></nlm-citation>
</ref>
<ref id="B111">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rowhani-Rahbar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccine]]></article-title>
<source><![CDATA[Vaccine]]></source>
<year>2009</year>
<numero>27</numero>
<issue>27</issue>
<page-range>5612-9</page-range></nlm-citation>
</ref>
<ref id="B112">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castle]]></surname>
<given-names><![CDATA[PE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica.]]></article-title>
<source><![CDATA[J Infect Dis.]]></source>
<year>2005</year>
<numero>191</numero>
<issue>191</issue>
<page-range>1808-16</page-range></nlm-citation>
</ref>
<ref id="B113">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Franceschi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Variations in the age-specific curves of human papillomavirus prevalence in women worldwide]]></article-title>
<source><![CDATA[Int J Cancer.]]></source>
<year>2006</year>
<numero>119</numero>
<issue>119</issue>
<page-range>2677-84</page-range></nlm-citation>
</ref>
<ref id="B114">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Naud]]></surname>
<given-names><![CDATA[PS]]></given-names>
</name>
<name>
<surname><![CDATA[Roteli-Martins]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[DeCarvalho]]></surname>
<given-names><![CDATA[NS]]></given-names>
</name>
<name>
<surname><![CDATA[Teixeira]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[de Borba]]></surname>
<given-names><![CDATA[PC]]></given-names>
</name>
<name>
<surname><![CDATA[Sanchez]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sustained efficacy, immunogenicity, and safety of the HPV-16/18 ASO4-adjuvanted vaccine.]]></article-title>
<source><![CDATA[Hum Vaccin Immunother]]></source>
<year>2014</year>
<volume>10</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>2147-62</page-range></nlm-citation>
</ref>
<ref id="B115">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arnheim-Dahlstrom]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Pasternak]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Svanstrom]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Sparen]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Hviid]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Autoimmune, neurological, and venous thromboembolic adverse events after immunization of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study.]]></article-title>
<source><![CDATA[BMJ]]></source>
<year>2013</year>
<numero>347</numero>
<issue>347</issue>
<page-range>f5906</page-range></nlm-citation>
</ref>
<ref id="B116">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Scheller]]></surname>
<given-names><![CDATA[NM]]></given-names>
</name>
<name>
<surname><![CDATA[Svanstrom]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Pasternak]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Arnheim-Dahlstrom]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Sundstrom]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Fink]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system.]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2015</year>
<volume>313</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>54-61</page-range></nlm-citation>
</ref>
<ref id="B117">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Little]]></surname>
<given-names><![CDATA[DT]]></given-names>
</name>
<name>
<surname><![CDATA[Ward]]></surname>
<given-names><![CDATA[HRG.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adolescent premature ovarian insufficiency following human papillomavirus vaccination: a case series seen in general practice.]]></article-title>
<source><![CDATA[J Inv Med High Imp Case Rep.]]></source>
<year>2014</year>
<page-range>1-12</page-range></nlm-citation>
</ref>
<ref id="B118">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Colafrancesco]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Perricone]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Tomljenovic]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Shoenfeld]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Human papilloma virus vaccine and primary ovarian failure: another facet of the autoimmune/inflammatory syndrome induced by adjuvants.]]></article-title>
<source><![CDATA[Am J Reprod Immunol]]></source>
<year>2013</year>
<numero>70</numero>
<issue>70</issue>
<page-range>309-16</page-range></nlm-citation>
</ref>
<ref id="B119">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grimaldi-Bensouda]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Guillemot]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Godeau]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Benichou]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lebrun-Frenay]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Papeix]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects.]]></article-title>
<source><![CDATA[J Int Med.]]></source>
<year>2014</year>
<numero>275</numero>
<issue>275</issue>
<page-range>398-408</page-range></nlm-citation>
</ref>
<ref id="B120">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jena]]></surname>
<given-names><![CDATA[AB]]></given-names>
</name>
<name>
<surname><![CDATA[Goldman]]></surname>
<given-names><![CDATA[DP]]></given-names>
</name>
<name>
<surname><![CDATA[Sealbury]]></surname>
<given-names><![CDATA[SA.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidence of sexually transmitted infections after human papillomavirus vaccination among adolescent females]]></article-title>
<source><![CDATA[JAMA Intern Med.]]></source>
<year>2015</year>
<volume>175</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>617-23</page-range></nlm-citation>
</ref>
<ref id="B121">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bednarczyk]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Davis]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Ault]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Orenstein]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Omer]]></surname>
<given-names><![CDATA[SB.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds]]></article-title>
<source><![CDATA[Pediatrics]]></source>
<year>2012</year>
<volume>130</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>798-805</page-range></nlm-citation>
</ref>
<ref id="B122">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Little]]></surname>
<given-names><![CDATA[DT]]></given-names>
</name>
<name>
<surname><![CDATA[Ward]]></surname>
<given-names><![CDATA[HRG.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adolescent premature ovarian insufficiency following human papillomavirus vaccination: a case series seen in general practice.]]></article-title>
<source><![CDATA[J Inv Med High Imp Case Rep.]]></source>
<year>2014</year>
</nlm-citation>
</ref>
<ref id="B123">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Colafrancesco]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Perricone]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Tomljenovic]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Shoenfeld]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Human papilloma virus vaccine and primary ovarian failure: another facet of the autoimmune/inflammatory syndrome induced by adjuvants]]></article-title>
<source><![CDATA[Am J Reprod Immunol]]></source>
<year>2013</year>
<numero>70</numero>
<issue>70</issue>
<page-range>309-16</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
